USPTO serial 76311406
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E. Abelman
LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND ST FL 26NEW YORK, NY 10017-5621UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 029 | Meat, fish, poultry and game; meat extracts; preserved, dried and cooked fruits and vegetables; jellies, jams, fruit sauces; eggs, milk and milk products; edible oils and fats | ACTIVE | — |
| 030 | Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, bread pastry and confectionery, ices; honey treacle; yeast, baking powder; salt, mustard; vinegar, sauces (condiments); spices; ice | ACTIVE | — |
| 031 | Agricultural and horticultural products and grains not included in other classes; live animals including live fish and shellfish; fresh fruit and vegetables; seeds; foodstuffs for animals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 15, 2002 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Dec 19, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 5, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2001 | DOCK | ASSIGNED TO EXAMINER | — |